UroGen Pharma Income Statement (2016-2025) | URGN

Income Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 23.06M0.02M79.04M7.81M0.33M0.48M0.36M0.28M0.02M3.46M7.97M7.49M13.03M11.35M16.17M13.56M16.60M16.10M18.09M17.19M21.14M20.85M23.53M18.78M21.85M25.20M24.57M20.25M24.21M27.48M
Cost of Revenue 0.02M0.29M0.29M0.43M0.32M1.05M0.31M0.65M0.90M1.43M1.24M1.59M1.52M1.85M2.02M2.26M2.27M2.44M2.37M2.29M1.73M2.23M2.45M2.47M2.33M3.55M3.28M
Gross Profit 1.00M-1.00M7.52M0.04M0.05M0.05M-0.77M3.15M7.31M6.59M11.61M10.11M14.59M12.04M14.76M14.08M15.83M14.93M18.70M18.48M21.24M17.05M19.62M22.75M22.09M17.92M20.66M24.20M
Operating items
Research & Development 2.87M2.37M2.66M3.65M5.62M6.76M7.62M8.27M9.57M11.46M9.73M10.00M9.48M20.09M16.59M10.21M12.40M10.51M12.12M11.92M13.08M12.70M12.64M13.09M14.48M12.50M11.58M10.23M11.30M15.49M15.40M11.36M14.89M19.87M18.91M14.01M
Selling, General & Administrative 3.24M1.23M0.88M2.30M2.20M3.44M6.07M10.21M10.74M12.55M12.71M13.78M13.97M19.75M21.97M22.07M22.16M22.19M22.30M21.62M21.42M21.30M20.83M19.07M21.63M24.47M22.49M21.75M24.55M27.30M30.06M28.94M34.86M34.97M43.20M37.58M
Other Operating Expenses -4.25M
Operating Expenses 6.11M3.60M3.54M5.95M7.82M5.95M13.69M18.48M20.32M24.02M22.43M23.77M23.45M39.84M38.56M32.28M34.57M32.70M34.43M33.55M34.50M34.00M33.47M32.16M36.11M36.97M34.08M31.98M35.85M42.79M45.46M40.30M49.75M54.84M62.11M51.59M
Operating Income 13.90M-3.54M-6.95M-0.30M-5.95M-13.64M-18.43M-21.09M-24.02M-22.43M-23.75M-23.45M-39.84M-38.56M-29.12M-27.25M-26.11M-22.82M-23.44M-19.91M-21.96M-18.71M-18.09M-20.28M-22.05M-15.38M-13.50M-14.61M-25.74M-25.84M-17.55M-27.66M-36.91M-41.45M-27.39M
EBIT 13.90M-3.54M-6.95M-0.30M-5.95M-13.64M-18.43M-21.09M-24.02M-22.43M-23.75M-23.45M-39.84M-38.56M-29.12M-27.25M-26.11M-22.82M-23.44M-19.91M-21.96M-18.71M-18.09M-20.28M-22.05M-15.38M-13.50M-14.61M-25.74M-25.84M-17.55M-27.66M-36.91M-41.45M-27.39M
Non-operating items
Interest & Investment Income -0.12M0.25M-0.01M-0.36M-0.41M-0.56M0.77M0.31M0.27M0.24M0.06M0.02M0.00M0.13M0.48M0.41M0.63M0.41M0.91M1.54M1.61M1.71M2.60M2.75M2.11M1.30M0.98M
Non Operating Income 1.88M-0.98M-0.01M0.09M0.26M0.99M0.18M-0.24M-0.02M-0.08M-0.00M0.10M0.04M-0.40M-0.01M-0.03M0.07M-0.71M
Net income details
EBT 12.92M-3.66M-6.70M-0.31M-10.07M-14.00M-18.84M-21.64M-24.02M-22.43M-23.75M-23.45M-39.84M-37.79M-28.82M-27.15M-25.93M-25.91M-30.21M-27.32M-28.07M-26.66M-25.12M-28.18M-30.19M-24.08M-21.89M-22.16M-32.23M-33.37M-23.58M-34.86M-43.45M-48.92M-34.40M
Tax Provisions 3.37M0.31M1.14M0.33M0.03M0.71M0.69M0.02M0.05M-0.01M3.85M0.05M0.04M0.09M2.65M0.39M1.01M-1.05M
Profit After Tax 7.99M-16.80M-3.42M6.20M-0.30M-10.09M-13.38M-18.03M-20.53M-23.72M-21.44M-22.48M-22.25M-38.97M-37.79M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Income from Continuing Operations 12.92M-3.66M-6.70M-0.31M-10.07M-14.00M-18.84M-21.64M-24.02M-22.43M-23.75M-23.45M-39.84M-37.79M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Consolidated Net Income 12.92M-3.66M-6.70M-0.31M-10.07M-14.00M-18.84M-21.64M-24.02M-22.43M-23.75M-23.45M-39.84M-37.79M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Income towards Parent Company 12.92M-3.66M-6.70M-0.31M-10.07M-14.00M-18.84M-21.64M-24.02M-22.43M-23.75M-23.45M-39.84M-37.79M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Net Income towards Common Stockholders 12.92M-3.66M-6.70M-0.31M-10.07M-14.00M-18.84M-21.64M-24.02M-22.43M-23.75M-23.45M-39.84M-37.79M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Additional items
EPS (Basic) 0.99-1.74-0.52-0.020.36-0.88-1.14-1.28-1.461.11-1.08-1.06-1.86-1.78-1.31-1.38-1.17-1.17-1.35-1.27-1.25-1.18-1.13-1.25-1.30-1.03-0.68-0.72-0.87-0.82-0.51-0.80-0.92-1.05-0.69
EPS (Weighted Average and Diluted) 0.01M1.560.00M0.01M303.000.740.01M0.02M0.02M
Shares Outstanding (Weighted Average) 13.01M13.01M13.01M13.01M13.01M13.75M13.75M13.75M13.75M20.48M20.79M20.90M20.98M21.15M21.94M22.02M22.09M22.27M22.28M22.36M22.42M22.67M22.69M22.74M23.09M23.44M23.45M30.28M30.87M34.12M36.13M42.11M42.20M46.09M46.11M46.26M
Shares Outstanding (Diluted Average) 8.29M9.20M13.61M
EBITDA 13.90M-3.54M-6.95M-0.30M-5.95M-13.64M-13.38M-20.53M-23.72M-22.43M-21.44M-22.23M-39.00M-37.76M-29.08M-30.75M-26.06M-26.32M-30.25M-28.48M-28.44M-26.68M-25.93M-28.82M-30.15M-24.25M-21.86M-25.87M-32.34M-33.40M-23.41M-37.69M-43.88M-49.95M-33.33M
Tax Rate 0.04%3.06%